Evidence map›Paper›PMID 34925812›Full record

ArticleFood science & nutrition2021

Beneficial effects of a nobiletin-rich formulated supplement of Sikwasa (

Shizuo Yamada, Michiyo Shirai, Ken Ono, Toshiaki Teruya, Aki Yamano, Je Tae Woo

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Nobiletin as an inducer of programmed cell death in cancer: a review.Apoptosis : an international journal on programmed cell death · 2022
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Shizuo YamadaCenter for Pharma-Food Research Graduate School of Pharmaceutical Sciences University of Shizuoka Shizuoka Japan.ORCID https://orcid.org/0000-0002-5915-9863
Michiyo ShiraiCenter for Pharma-Food Research Graduate School of Pharmaceutical Sciences University of Shizuoka Shizuoka Japan.
Ken OnoIzu Health & Medical Center Shizuoka Japan.
Toshiaki TeruyaFaculty of Education University of the Ryukyus Okinawa Japan.
Aki YamanoOkinawa Research Center Co., Ltd Uruma Japan.
Je Tae WooOkinawa Research Center Co., Ltd Uruma Japan.
University of Shizuoka · JPChubu University · JPShizuoka Medical Center · JPUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNobiletin exerts beneficial effects on cognitive function in various animal models of Alzheimer's disease. The present study aimed to investigate the benefits and safety of a combination food of nobiletin-rich extract from

methodsThe nobiletin-containing test food (Nobilex

resultsThe scores of "general memory" or "visual memory" in the indices of WMS-R were significantly higher in the nobiletin-containing test food group than in the placebo group. The difference in the total WMS-R score was significantly higher in the test-food group (9.0 ± 7.20) than in the placebo group (5.9 ± 7.70). An age-stratified analysis of the WMS-R test showed similar changes in subjects aged ≦74 years to those in the overall subject population. In the stratified analysis involving subjects with an MMSE-J score of between 24 and 28, the "figural memory" subscale score in WMS-R was significantly higher in the test food group than in the placebo group.

conclusionThe present results indicate that the nobiletin-containing test food is beneficial for improving memory dysfunction in healthy elderly subjects.

Indexed as

elderly subjectmemory functionNobiletinWMS‐R

Identifiers

PMID34925812
PMCPMC8645756
OpenAlexW3208290596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.